National Cancer Institute

Showing 3 posts of 3 posts found.

TILT Biotherapeutics shares data on TILT-123 with Keytruda for ovarian cancer treatment

April 10, 2024
Research and Development Merck, National Cancer Institute, Oncology, TILT Biotherapeutics, keytruda, ovarian cancer

TILT Biotherapeutics has announced promising preliminary safety and efficacy data from its ongoing phase 1 clinical trial (NCT05271318) in platinum …

Shooting for the moon: The National Cancer Institute’s Formulary

July 28, 2017
Medical Communications National Cancer Institute, biotech, drugs, pharma, pharmaceutical

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

credit-_pdxnative

Trump appoints new Director of the National Cancer Institute

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment

Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …

Latest content